Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD 22.26
-0.24 (-1.07%)
Aug 15, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 55.17 billion as of August 15, 2025. Its market cap has increased by 60.56% in one year.
Market Cap
55.17B
Enterprise Value
59.39B
Revenue
13.62B
Ranking
n/a
PE Ratio
27.54
Stock Price
22.26
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 55.17B, an increase of 555.16%. That is a compound annual growth rate of 33.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 55.17B | 23.90% |
| Dec 31, 2024 | 44.53B | -14.67% |
| Dec 29, 2023 | 52.19B | -40.01% |
| Dec 30, 2022 | 86.99B | -33.39% |
| Dec 31, 2021 | 130.60B | 16.63% |
| Dec 31, 2020 | 111.98B | 155.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 266.94B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 175.53B |
| Innovent Biologics | 166.99B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |